Drug interactions
Empagliflozin-linagliptin + Metolazone
Severity: Moderate
Empagliflozin-linagliptin and Metolazone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Empagliflozin causes osmotic diuresis and metolazone is a potent thiazide-like diuretic, so combined use can lead to marked fluid and sodium loss. This may result in hypovolemia, hypotension, electrolyte disturbance and worsening renal function.
What this interaction means in plain words
Empagliflozin-linagliptin and Metolazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Empagliflozin-linagliptin belongs to Endocrine; Metolazone belongs to Cardiovascular.
Why it happens
Additive diuretic and natriuretic effects of the SGLT2 inhibitor and the thiazide-like diuretic.
What to do
Monitor volume status, blood pressure, electrolytes and renal function after initiation. Consider lowering the diuretic dose if volume depletion develops.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Metolazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Other interactions of Metolazone
Frequently asked questions
Can I take Empagliflozin-linagliptin with Metolazone?
MediHelp rates the interaction as moderate. Empagliflozin-linagliptin and Metolazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Empagliflozin causes osmotic diuresis and metolazone is a potent thiazide-like diuretic, so combined use can lead to marked fluid and sodium loss. This may result in hypovolemia, hypotension, electrolyte disturbance and worsening renal function.
How serious is the interaction between Empagliflozin-linagliptin and Metolazone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor volume status, blood pressure, electrolytes and renal function after initiation. Consider lowering the diuretic dose if volume depletion develops.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
